Industry events in science and tech: deals, launches, company and regulator decisions.
Replit CEO Amjad Masad stated that the company switched from Anthropic to OpenAI because ChatGPT performs better in building applications and is more cost-effective. The decision relied on internal benchmarks comparing Sol and Astra models.
The Rhode Island Brain Health Collaboratory has launched, uniting Cognito Therapeutics with local health systems to conduct clinical research and deploy neuromodulation protocols via the Spectris platform. The company states that Spectris AD received FDA Breakthrough Device designation and that Cognito has raised over $220 million in private financing.
Health tech startup Ultrahuman signed a two-year MoU with Abu Dhabi Public Health Center to develop a model combining clinical biomarkers and wearable device data.
Researchers from the National Institute for Innovation in Manufacturing Biopharmaceuticals and the University of Delaware demonstrated how R&D and supply chain data become predictive assets. The MELLODDY Consortium model enables standardized sharing of key insights while protecting proprietary information.